| Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston, JCC Lorenzi, ... elife 9, e61312, 2020 | 1498 | 2020 |
| Nef proteins from simian immunodeficiency viruses are tetherin antagonists F Zhang, SJ Wilson, WC Landford, B Virgen, D Gregory, MC Johnson, ... Cell host & microbe 6 (1), 54-67, 2009 | 421 | 2009 |
| Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination A Cho, F Muecksch, D Schaefer-Babajew, Z Wang, S Finkin, C Gaebler, ... Nature 600 (7889), 517-522, 2021 | 277 | 2021 |
| Identification of interferon-stimulated genes with antiretroviral activity M Kane, TM Zang, SJ Rihn, F Zhang, T Kueck, M Alim, J Schoggins, ... Cell host & microbe 20 (3), 392-405, 2016 | 256 | 2016 |
| Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies … Z Chen, L Zhang, C Qin, L Ba, CE Yi, F Zhang, Q Wei, T He, W Yu, J Yu, ... Journal of virology 79 (5), 2678-2688, 2005 | 239 | 2005 |
| Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals L Zhang, F Zhang, W Yu, T He, J Yu, CE Yi, L Ba, W Li, M Farzan, Z Chen, ... Journal of medical virology 78 (1), 1-8, 2006 | 227 | 2006 |
| High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape F Schmidt, Y Weisblum, M Rutkowska, D Poston, J DaSilva, F Zhang, ... Nature 600 (7889), 512-516, 2021 | 214 | 2021 |
| Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity D Perez-Caballero, T Hatziioannou, F Zhang, S Cowan, PD Bieniasz Journal of virology 79 (24), 15567-15572, 2005 | 197 | 2005 |
| Generation of simian-tropic HIV-1 by restriction factor evasion T Hatziioannou, M Princiotta, M Piatak Jr, F Yuan, F Zhang, JD Lifson, ... Science 314 (5796), 95-95, 2006 | 187 | 2006 |
| Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china L Zhang, Z Chen, Y Cao, J Yu, G Li, W Yu, N Yin, S Mei, L Li, P Balfe, T He, ... Journal of virology 78 (24), 13591-13599, 2004 | 174 | 2004 |
| Antiretroviral potential of human tripartite motif-5 and related proteins F Zhang, T Hatziioannou, D Perez-Caballero, D Derse, PD Bieniasz Virology 353 (2), 396-409, 2006 | 162 | 2006 |
| SIV Nef proteins recruit the AP-2 complex to antagonize Tetherin and facilitate virion release F Zhang, WN Landford, M Ng, MW McNatt, PD Bieniasz, T Hatziioannou PLoS pathogens 7 (5), e1002039, 2011 | 84 | 2011 |
| Single-cell and single-cycle analysis of HIV-1 replication M Holmes, F Zhang, PD Bieniasz PLoS pathogens 11 (6), e1004961, 2015 | 75 | 2015 |
| HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137 F Zhang, PD Bieniasz Elife 9, e55806, 2020 | 64 | 2020 |
| Clathrin facilitates the morphogenesis of retrovirus particles F Zhang, T Zang, SJ Wilson, MC Johnson, PD Bieniasz PLoS Pathogens 7 (6), e1002119, 2011 | 59 | 2011 |
| No effect of endogenous TRIM5α on HIV-1 production F Zhang, D Perez-Caballero, T Hatziioannou, PD Bieniasz Nature medicine 14 (3), 235-236, 2008 | 44 | 2008 |
| Human APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity HP Bogerd, F Zhang, PD Bieniasz, BR Cullen Virology 410 (1), 234-239, 2011 | 29 | 2011 |
| Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis F Muecksch, H Wise, K Templeton, B Batchelor, M Squires, K McCance, ... The Lancet Microbe 3 (7), e493-e502, 2022 | 28 | 2022 |
| Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins F Zhang, TM Zang, EM Stevenson, X Lei, DC Copertino, TM Mota, ... Proceedings of the National Academy of Sciences 119 (41), e2209042119, 2022 | 25 | 2022 |
| Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity F Muecksch, H Wise, K Templeton, B Batchelor, M Squires, K McCance, ... MedRxiv, 2021 | 12 | 2021 |
